Back to GEODE CAPITAL MANAGEMENT, LLC GEODE CAPITAL MANAGEMENT, LLC

SGMOSGMO
Showing 8 of 31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLCGEODE CAPITAL MANAGEMENT, LLC's holdings in SANGAMO THERAPEUTICS INC

GEODE CAPITAL MANAGEMENT, LLC previously held 0 shares of SGMO (SANGAMO THERAPEUTICS INC), worth $0 as of 2026-Q2.

Final Value

$0

Final Shares

0

Total Value Change

-$1.9M

Total Shares Change

-2.1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Exited
0
-100.0%
$00.0%$0.14
0
2026-Q1
Increased
4.6M
+18.2%
$1.1M0.0%$0.39
30
2025-Q4
Increased
3.9M
+17.6%
$1.6M0.0%$0.43
30
2025-Q3
Increased
3.3M
+40.9%
$2.2M0.0%$0.70
35
2025-Q2
Increased
2.3M
+2.1%
$1.3M0.0%$0.54
26
2025-Q1
Increased
2.3M
+3.2%
$1.5M0.0%$0.82
26
2024-Q4
Increased
2.2M
+3.4%
$2.3M0.0%$2.34
27
2024-Q3
Increased
2.1M
+14.6%
$1.9M0.0%$0.87
29

Other major holders of SGMO: BNP PARIBAS FINANCIAL MARKETS, WASATCH ADVISORS LP

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used